Delayed gastrointestinal recovery after abdominal operation - Role of alvimopan

Clinical and Experimental Gastroenterology

Volumn 8, Issue , 2015, Pages 231-235

  Berger, Nicholas G ^a   Ridolfi, Timothy J ^a   Ludwig, Kirk A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Alvimopan; Bowel resection; Ileus; Postoperative ileus; Return of bowel function

Indexed keywords

ALVIMOPAN; PLACEBO;

ABDOMINAL DISTENSION; ABDOMINAL HYSTERECTOMY; ABDOMINAL SURGERY; CONTROLLED CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYSTECTOMY; DELAYED GASTROINTESTINAL RECOVERY; DRUG COST; DRUG SAFETY; FLATULENCE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL TRACT FUNCTION; HOSPITAL DISCHARGE; HUMAN; INTESTINE RESECTION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NAUSEA; PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE ILEUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VOMITING;

EID: 84940036963     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S64029     Document Type: Review

References (26)

1. Vather R, Trivedi S, Bissett I. Defining postoperative ileus: results of a systematic review and global survey. J Gastrointest Surg. 2013; 17(5): 962-972.
2. Kalff JC, Schraut WH, Simmons RL, Bauer AJ. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg. 1998; 228(5): 652-663.
3. Bohn LM, Raehal KM. Opioid receptor signaling: relevance for gastrointestinal therapy. Curr Opin Pharmacol. 2006; 6(6): 559-563.
4. Goldstein JL, Matuszewski KA, Delaney CP, et al. Inpatient economic burden of postoperative ileus associated with abdominal surgery in the United States. P T. 2007; 32(2): 82-90.
5. Basse L, Thorbøl JE, Løssl K, Kehlet H. Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum. 2004; 47(3): 271-277; discussion 277-278.
6. Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet. 2009; 373(9670): 1198-1206.
7. Taguchi A, Sharma N, Saleem RM, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med. 2001; 345(13): 935-940.
8. Delaney CP, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum. 2005; 48(6): 1114-1125; discussion 1125-1126; author reply 1127-1129.
9. Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc. 2006; 20(1): 64-70.
10. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg. 2004; 240(4): 728-734; discussion 734-735.
11. Herzog TJ, Coleman RL, Guerrieri JP Jr, et al. A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy. Am J Obstet Gynecol. 2006; 195(2): 445-453.
12. Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg. 2008; 143(11): 1098-1105.
13. Ludwig K, Viscusi ER, Wolff BG, Delaney CP, Senagore A, Techner L. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis. World J Surg. 2010; 34(9): 2185-2190.
14. Tan EK, Cornish J, Darzi AW, Tekkis PP. Meta-analysis: alvimopan vs placebo in the treatment of post-operative ileus. Aliment Pharmacol Ther. 2007; 25(1): 47-57.
15. Vaughan-Shaw PG, Fecher IC, Harris S, Knight JS. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. Dis Colon Rectum. 2012; 55(5): 611-620.
16. Lee CT, Chang SS, Kamat AM, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol. 2014; 66(2): 265-272.
17. Wolff BG, Weese JL, Ludwig KA, et al. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. J Am Coll Surg. 2007; 204(4): 609-616.
18. Mortensen E. Entereg® (alvimopan) OBD study GSK014 safety findings. 2008. Available from: http://www. fda. gov/ohrms/dockets/ac/08/slides/2008-4336s1-04-Adolor-Mortensen. pdf. Accessed June 2, 2015.
19. Cubist Pharmaceuticals I. Entereg (alvimopan) risk evaluation and mitigation strategy (REMS). 2013. Available from: http://www. accessdata. fda. gov/drugsatfda_docs/label/2013/021775s010lbl. pdf. Accessed June 2, 2015.
20. Kauf TL, Svatek RS, Amiel G, et al. Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial. J Urol. 2014; 191(6): 1721-1727.
21. Poston S, Broder MS, Gibbons MM, et al. Impact of alvimopan (Entereg) on hospital costs after bowel resection: results from a large inpatient database. P T. 2011; 36(4): 209-220.
22. Simorov A, Thompson J, Oleynikov D. Alvimopan reduces length of stay and costs in patients undergoing segmental colonic resections: results from multicenter national administrative database. Am J Surg. 2014; 208(6): 919-925; discussion 925.
23. Delgado S, Lacy AM, Filella X, et al. Acute phase response in laparoscopic and open colectomy in colon cancer: randomized study. Dis Colon Rectum. 2001; 44(5): 638-646.
24. Obokhare ID, Champagne B, Stein SL, Krpata D, Delaney CP. The effect of alvimopan on recovery after laparoscopic segmental colectomy. Dis Colon Rectum. 2011; 54(6): 743-746.
25. Kelley SR, Wolff BG, Lovely JK, Larson DW. Fast-track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg): which is more cost-effective? Am Surg. 2013; 79(6): 630-633.
26. Lau C, Phillips E, Bresee C, Fleshner P. Early use of low residue diet is superior to clear liquid diet after elective colorectal surgery: a randomized controlled trial. Ann Surg. 2014; 260(4): 641-647; discussion 647-649.